PERCEPTIVE ADVISORS LLC

Q4 2023 13F-HR/A Holdings

Location
New York, NY
Holdings as of
12/31/2023
Date filed
2/26/2024
Form type
13F-HR/A - RESTATEMENT
Num holdings
101
Total value ($000)
$4,479,992
Net value change ($000)
+1,482,082 (49.4%)
New positions
20
Sold out positions
10
Turnover %
10.6%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/14/2023 Next filing: 8/6/2024 SEC filing

Snapshot: Change Analysis

Compared to Q3 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Cerevel Therapeutics Holdings, Inc. 244,695 111.1%
LIANY 171,494 200.0%
ACLX 109,938 77.3%
NUVL 101,490 89.6%
RYTM 90,294 1034.3%
Inhibrx, Inc. 83,632 107.1%
CRGX 79,557 NEW
FOLD 61,389 18.2%
SYRE 55,102 5543.5%
BHVN 54,277 277.6%
Top Reduces (Value $000, Stocks/ETFs)
ARGX -74,039 -100.0%
AKRO -59,313 -72.4%
IMVT -48,364 -33.0%
ALDX -45,656 -60.2%
ROIV -44,611 -100.0%
HRMY -32,649 -100.0%
AMLX -21,719 -44.1%
RLAY -16,341 -100.0%
TNGX -16,230 -59.6%
COGT -15,914 -70.7%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 6,575 (0.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type